Effects of phenformin on the proliferation of human tumor cell lines

Filippo Caraci, Mariangela Chisari, Giuseppina Frasca, Santina Chiechio, Salvatore Salomone, Antonio Pinto, Maria Angela Sortino, Alfredo Bianchi

Research output: Contribution to journalArticle

Abstract

Phenformin is a biguanide that has been largely used in the past for its anti-diabetic activity. A large body of evidence suggests additional effects of phenformin including antitumoral activity in different animal models in vivo. Thus, the present study has been conducted in order to elucidate possible mechanisms involved in the antitumoral effects of phenformin. In various tumoral cell lines (SH-SY5Y neuroblastoma and LNCaP prostate adenocarcinoma cells), increasing concentrations of phenformin (50-500 μM) induced a concentration-dependent inhibition of cell proliferation. This effect was not dependent on the ability of the drug to reduce glucose levels and was accompanied by induction of apoptotic cell death as measured by cytofluorometric analysis. In addition, a short-time incubation of SH-SY5Y cells with phenformin induced enhanced and transient expression of the cell cycle inhibitor p21 suggesting that phenformin causes inhibition of cell cycle progression prior to induction of apoptosis. These results demonstrate an activity at the cellular level of phenformin that supports its antitumoral effect observed in vivo.

Original languageEnglish
Pages (from-to)643-650
Number of pages8
JournalLife Sciences
Volume74
Issue number5
DOIs
Publication statusPublished - Dec 19 2003

Fingerprint

Phenformin
Tumor Cell Line
Tumors
Cells
Cell Cycle
Biguanides
Cell proliferation
Cell death
Neuroblastoma
Prostate
Animals
Adenocarcinoma
Cell Death
Animal Models
Cell Proliferation
Apoptosis
Glucose
Cell Line

Keywords

  • Apoptosis
  • Cell cycle
  • Cell growth
  • Toxicity

ASJC Scopus subject areas

  • Pharmacology

Cite this

Caraci, F., Chisari, M., Frasca, G., Chiechio, S., Salomone, S., Pinto, A., ... Bianchi, A. (2003). Effects of phenformin on the proliferation of human tumor cell lines. Life Sciences, 74(5), 643-650. https://doi.org/10.1016/j.lfs.2003.07.015

Effects of phenformin on the proliferation of human tumor cell lines. / Caraci, Filippo; Chisari, Mariangela; Frasca, Giuseppina; Chiechio, Santina; Salomone, Salvatore; Pinto, Antonio; Sortino, Maria Angela; Bianchi, Alfredo.

In: Life Sciences, Vol. 74, No. 5, 19.12.2003, p. 643-650.

Research output: Contribution to journalArticle

Caraci, F, Chisari, M, Frasca, G, Chiechio, S, Salomone, S, Pinto, A, Sortino, MA & Bianchi, A 2003, 'Effects of phenformin on the proliferation of human tumor cell lines', Life Sciences, vol. 74, no. 5, pp. 643-650. https://doi.org/10.1016/j.lfs.2003.07.015
Caraci F, Chisari M, Frasca G, Chiechio S, Salomone S, Pinto A et al. Effects of phenformin on the proliferation of human tumor cell lines. Life Sciences. 2003 Dec 19;74(5):643-650. https://doi.org/10.1016/j.lfs.2003.07.015
Caraci, Filippo ; Chisari, Mariangela ; Frasca, Giuseppina ; Chiechio, Santina ; Salomone, Salvatore ; Pinto, Antonio ; Sortino, Maria Angela ; Bianchi, Alfredo. / Effects of phenformin on the proliferation of human tumor cell lines. In: Life Sciences. 2003 ; Vol. 74, No. 5. pp. 643-650.
@article{193b8b2775c545d3aeba37356356fcfe,
title = "Effects of phenformin on the proliferation of human tumor cell lines",
abstract = "Phenformin is a biguanide that has been largely used in the past for its anti-diabetic activity. A large body of evidence suggests additional effects of phenformin including antitumoral activity in different animal models in vivo. Thus, the present study has been conducted in order to elucidate possible mechanisms involved in the antitumoral effects of phenformin. In various tumoral cell lines (SH-SY5Y neuroblastoma and LNCaP prostate adenocarcinoma cells), increasing concentrations of phenformin (50-500 μM) induced a concentration-dependent inhibition of cell proliferation. This effect was not dependent on the ability of the drug to reduce glucose levels and was accompanied by induction of apoptotic cell death as measured by cytofluorometric analysis. In addition, a short-time incubation of SH-SY5Y cells with phenformin induced enhanced and transient expression of the cell cycle inhibitor p21 suggesting that phenformin causes inhibition of cell cycle progression prior to induction of apoptosis. These results demonstrate an activity at the cellular level of phenformin that supports its antitumoral effect observed in vivo.",
keywords = "Apoptosis, Cell cycle, Cell growth, Toxicity",
author = "Filippo Caraci and Mariangela Chisari and Giuseppina Frasca and Santina Chiechio and Salvatore Salomone and Antonio Pinto and Sortino, {Maria Angela} and Alfredo Bianchi",
year = "2003",
month = "12",
day = "19",
doi = "10.1016/j.lfs.2003.07.015",
language = "English",
volume = "74",
pages = "643--650",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Effects of phenformin on the proliferation of human tumor cell lines

AU - Caraci, Filippo

AU - Chisari, Mariangela

AU - Frasca, Giuseppina

AU - Chiechio, Santina

AU - Salomone, Salvatore

AU - Pinto, Antonio

AU - Sortino, Maria Angela

AU - Bianchi, Alfredo

PY - 2003/12/19

Y1 - 2003/12/19

N2 - Phenformin is a biguanide that has been largely used in the past for its anti-diabetic activity. A large body of evidence suggests additional effects of phenformin including antitumoral activity in different animal models in vivo. Thus, the present study has been conducted in order to elucidate possible mechanisms involved in the antitumoral effects of phenformin. In various tumoral cell lines (SH-SY5Y neuroblastoma and LNCaP prostate adenocarcinoma cells), increasing concentrations of phenformin (50-500 μM) induced a concentration-dependent inhibition of cell proliferation. This effect was not dependent on the ability of the drug to reduce glucose levels and was accompanied by induction of apoptotic cell death as measured by cytofluorometric analysis. In addition, a short-time incubation of SH-SY5Y cells with phenformin induced enhanced and transient expression of the cell cycle inhibitor p21 suggesting that phenformin causes inhibition of cell cycle progression prior to induction of apoptosis. These results demonstrate an activity at the cellular level of phenformin that supports its antitumoral effect observed in vivo.

AB - Phenformin is a biguanide that has been largely used in the past for its anti-diabetic activity. A large body of evidence suggests additional effects of phenformin including antitumoral activity in different animal models in vivo. Thus, the present study has been conducted in order to elucidate possible mechanisms involved in the antitumoral effects of phenformin. In various tumoral cell lines (SH-SY5Y neuroblastoma and LNCaP prostate adenocarcinoma cells), increasing concentrations of phenformin (50-500 μM) induced a concentration-dependent inhibition of cell proliferation. This effect was not dependent on the ability of the drug to reduce glucose levels and was accompanied by induction of apoptotic cell death as measured by cytofluorometric analysis. In addition, a short-time incubation of SH-SY5Y cells with phenformin induced enhanced and transient expression of the cell cycle inhibitor p21 suggesting that phenformin causes inhibition of cell cycle progression prior to induction of apoptosis. These results demonstrate an activity at the cellular level of phenformin that supports its antitumoral effect observed in vivo.

KW - Apoptosis

KW - Cell cycle

KW - Cell growth

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=0242459925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242459925&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2003.07.015

DO - 10.1016/j.lfs.2003.07.015

M3 - Article

C2 - 14623034

AN - SCOPUS:0242459925

VL - 74

SP - 643

EP - 650

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 5

ER -